Literature DB >> 33412518

Function of Deptor and its roles in hematological malignancies.

Mario Morales-Martinez1, Alan Lichtenstein2, Mario I Vega1,2.   

Abstract

Deptor is a protein that interacts with mTOR and that belongs to the mTORC1 and mTORC2 complexes. Deptor is capable of inhibiting the kinase activity of mTOR. It is well known that the mTOR pathway is involved in various signaling pathways that are involved with various biological processes such as cell growth, apoptosis, autophagy, and the ER stress response. Therefore, Deptor, being a natural inhibitor of mTOR, has become very important in its study. Because of this, it is important to research its role regarding the development and progression of human malignancies, especially in hematologic malignancies. Due to its variation in expression in cancer, it has been suggested that Deptor can act as an oncogene or tumor suppressor depending on the cellular or tissue context. This review discusses recent advances in its transcriptional and post-transcriptional regulation of Deptor. As well as the advances regarding the activities of Deptor in hematological malignancies, its possible role as a biomarker, and its possible clinical relevance in these malignancies.

Entities:  

Keywords:  Deptor; Multiple Myeloma; Non-Hodgkin Lymphoma; hematological malignances; leukemia

Mesh:

Substances:

Year:  2021        PMID: 33412518      PMCID: PMC7834987          DOI: 10.18632/aging.202462

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  230 in total

Review 1.  Chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi; Kanti R Rai; Manlio Ferrarini
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

2.  MicroRNA-150 Is up-regulated in extranodal marginal zone lymphoma of MALT type.

Authors:  Niklas Gebauer; Johannes Kuba; Andrea Senft; Arne Schillert; Veronica Bernard; Christoph Thorns
Journal:  Cancer Genomics Proteomics       Date:  2014 Jan-Feb       Impact factor: 4.069

3.  miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma.

Authors:  Hironori Matsuyama; Hiroshi I Suzuki; Hikaru Nishimori; Masaaki Noguchi; Takashi Yao; Norio Komatsu; Hiroyuki Mano; Koichi Sugimoto; Kohei Miyazono
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

4.  Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia.

Authors:  N C Gutiérrez; R López-Pérez; J M Hernández; I Isidro; B González; M Delgado; E Fermiñán; J L García; L Vázquez; M González; J F San Miguel
Journal:  Leukemia       Date:  2005-03       Impact factor: 11.528

5.  Gene expression profiles of cutaneous B cell lymphoma.

Authors:  Monique N Storz; Matt van de Rijn; Youn H Kim; Serena Mraz-Gernhard; Richard T Hoppe; Sabine Kohler
Journal:  J Invest Dermatol       Date:  2003-05       Impact factor: 8.551

6.  The forkhead transcription factor FOXP1 represses human plasma cell differentiation.

Authors:  Martine van Keimpema; Leonie J Grüneberg; Michal Mokry; Ruben van Boxtel; Menno C van Zelm; Paul Coffer; Steven T Pals; Marcel Spaargaren
Journal:  Blood       Date:  2015-08-19       Impact factor: 22.113

7.  Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

Authors:  M Shimoyama
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

8.  Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.

Authors:  Haoran Zhang; Junmin Chen; Zhiyong Zeng; Wenzhong Que; Linying Zhou
Journal:  Int J Mol Med       Date:  2013-03-12       Impact factor: 4.101

9.  Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma.

Authors:  Nicola Amodio; Maria Eugenia Gallo Cantafio; Cirino Botta; Valter Agosti; Cinzia Federico; Daniele Caracciolo; Domenica Ronchetti; Marco Rossi; Christoph Driessen; Antonino Neri; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Cancers (Basel)       Date:  2019-02-18       Impact factor: 6.639

Review 10.  The biological implications of Yin Yang 1 in the hallmarks of cancer.

Authors:  Ian Timothy Sembiring Meliala; Rendy Hosea; Vivi Kasim; Shourong Wu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.